DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Editor’s Message and Issue Highlights

Dear Colleagues: Welcome to the February 2011 issue of Innovations in Clinical Neuroscience.

Lisdexamfetamine Dimesylate for the Treatment of Attention Deficit Hyperactivity Disorder in Adults With a History of Depression or History of Substance Use Disorder

by Scott H. Kollins, PhD; Sharon Youcha, MD; Robert Lasser, MD, MBA; and Michael E. Thase, MD Dr. Kollins is from Duke ADHD Program, Duke University Medical Center, Durham, North